Peer Review reports
From: PI3K pathway activation results in low efficacy of both trastuzumab and lapatinib
| Original Submission | ||
|---|---|---|
| 16 Mar 2011 | Submitted | Original manuscript |
| 28 Mar 2011 | Author responded | Author comments - Xi-Chun Hu |
| Resubmission - Version 2 | ||
| 28 Mar 2011 | Submitted | Manuscript version 2 |
| 13 Apr 2011 | Reviewed | Reviewer Report - Maurizio Scaltriti |
| 21 Apr 2011 | Reviewed | Reviewer Report - Katherine Hale |
| 20 May 2011 | Author responded | Author comments - Xi-Chun Hu |
| Resubmission - Version 3 | ||
| 20 May 2011 | Submitted | Manuscript version 3 |
| 10 Jun 2011 | Author responded | Author comments - Xi-Chun Hu |
| Resubmission - Version 4 | ||
| 10 Jun 2011 | Submitted | Manuscript version 4 |
| Publishing | ||
| 15 Jun 2011 | Editorially accepted | |
| 15 Jun 2011 | Article published | 10.1186/1471-2407-11-248 |
You can find further information about peer review here.